AXL and neoplasm: Aguilera and collaborators suggested that in treatment unresponsive tumors, AXL was high expressed with antigen presentation suppressed through MHC-I, mediating immunological microenvironment reprogram and knockout of Axl in tumor cell lines increased surface MHC-I amounts in NF-κB independent pathway (84).